There is some evidence that lapatinib has activity in recurrent glioblastomas, but studies are ongoing.
It is in a trial” Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme, NCT00099060.
M. Touat A. Idbaih M. Sanson K. L. Ligon, Glioblastoma targeted therapy: updated approaches from recent biological insights Annals of Oncology, Volume 28, Issue 7, July 2017, Pages 1457–1472,
Yu a et al,
Report of safety
of pulse dosing of lapatinib with temozolomide and radiation therapy for newly-diagnosed glioblastoma in a pilot phase II study.J Neurooncol. 2017 Sep;134(2):357-362.